Search results
Found 7365 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Oxford researchers part of major UK initiative to understand chronic pain
10 May 2022
Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.
Professor Irene Tracey CBE FMedSci nominated as next Oxford Vice-Chancellor
10 May 2022
Professor Irene Tracey, Warden of Merton College, Oxford, has been nominated as the next Vice-Chancellor of the University of Oxford.
Introducing the Advanced Proteomics Facility
9 May 2022
This month we speak to Dr Marjorie Fournier, manager of the Advanced Proteomics Facility (APF) in the Department of Biochemistry about the facility's capabilities. The APF supports research and training activities in the field of mass spectrometry-based proteomics and is run by a team of expert scientists who support researchers from academia and industry on multidisciplinary research projects.
New Biochemistry Building renamed the Dorothy Crowfoot Hodgkin Building
5 May 2022
Dorothy Crowfoot Hodgkin made key contributions to Medical Sciences and was the third woman to win the Nobel Prize in Chemistry
Handling data securely
4 May 2022
Neither detection nor control of high blood pressure improved by self-monitoring during pregnancy
4 May 2022
Self-monitoring of blood pressure during pregnancy neither results in earlier detection of high blood pressure, nor helps with blood pressure control in those who are pregnant, suggest the results of two new papers based on research from the University of Oxford and King’s College London (funded by the National Institute of Health and Care Research).
Breakthrough in treatment for Dupuytren’s disease
30 April 2022
Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.
Tribute to Godfrey Fowler
29 April 2022
It is with great sadness that we share the news that Godfrey Fowler, the founding Head of Department at Nuffield Department of Primary Care Health Sciences, passed away on 29 March aged 90.
CAMS Oxford Institute unveiled at virtual ceremony
29 April 2022
Oxford University and the Chinese Academy of Medical Sciences (CAMS) signed a cooperation agreement at a virtual unveiling ceremony of the CAMS Oxford Institute.
How to use the science of the body clock to improve our sleep and health
28 April 2022
Jacqueline Pumphrey, April 2022
Oxford Clinical Medical Student tops prestigious national Ophthalmology Duke Elder Prize Examination
28 April 2022
Clinical Medical student, Peter Rae (Pembroke College, Year 5), placed first in the Royal College of Ophthalmology's annual examination
Paediatric IBD BioResource opens to support vital research
28 April 2022
A new National Institute for Health and Care Research (NIHR) BioResource aimed at investigating inflammatory bowel disease (IBD) in children has opened, with the NIHR Oxford BRC playing a key role.
World Malaria Day 2022
25 April 2022
Patient recruitment is on-track in the Oxford-led DeTACT trial of safe, effective drug combinations to prevent the spread of artemisinin and multi-drug resistant malaria in Africa.
Unique Oxford study of vascular disease reaches 20th anniversary
14 April 2022
The only project of its kind anywhere that studies patients with all types of acute vascular events – including strokes, heart attacks, aneurysms – in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.
Protease inhibitors safer than thought for pregnant women with HIV
13 April 2022
University of Oxford researchers assessed evidence from 34 studies, involving over 57,000 pregnant women with HIV, and found that protease inhibitor-based antiretroviral therapies significantly increased the risk of babies being small or very small for their gestational age, but there were no other adverse pregnancy outcomes, compared to therapies without protease inhibitors.
Diagnostic test could offer new hope for ME/CFS patients
13 April 2022
Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.
Introducing the Viral Vector Core Facility
11 April 2022
This month, we speak to Dr Claire Powers, manager of the Viral Vector Core Facility about the facilities capabilities, how you can access these facilities, and how the VVCF played a critical early role in the development of the Oxford/AZ vaccine.